Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$0.80 USD
+0.05 (7.21%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $0.79 -0.01 (-1.81%) 5:30 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Ironwood Pharmaceuticals, Inc. has a market cap of $121.45M, which represents its share price of $0.75 multiplied by its outstanding shares number of 161.82M. As a small-cap company, IRWD's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
IRWD 0.80 +0.05(7.21%)
Will IRWD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IRWD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IRWD
Why Is Ironwood (IRWD) Down 18.4% Since Last Earnings Report?
IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates
IRWD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates
Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Misses Revenue Estimates
Other News for IRWD
Vanguard Group Inc. Expands Stake in Ironwood Pharmaceuticals
Ardelyx: 'Hold' With Caution As Major Inflection Point Approaches
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
Ironwood Pharma Elects Directors at Annual Meeting